Hainan Haiyao Co., Ltd. (SHE:000566)
China · Delayed Price · Currency is CNY 4.780
-0.100 (-2.05%)
Sep 10, 2026, 12:44 PM CST
Hainan Haiyao Revenue
Hainan Haiyao had revenue of 153.08M CNY in the quarter ending June 30, 2026, a decrease of -37.18%. This brings the company's revenue in the last twelve months to 702.17M, down -17.15% year-over-year. In the year 2025, Hainan Haiyao had annual revenue of 831.18M, down -16.10%.
Revenue (ttm)
702.17M
Revenue Growth
-17.15%
P/S Ratio
9.02
Revenue / Employee
404.01K
Employees
1,738
Market Cap
6.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 831.18M | -159.52M | -16.10% |
| Dec 31, 2024 | 990.70M | -487.88M | -33.00% |
| Dec 31, 2023 | 1.48B | -300.47M | -16.89% |
| Jan 1, 2023 | 1.78B | -280.01M | -13.60% |
| Jan 1, 2022 | 2.06B | -141.25M | -6.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 4.87B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.73B |
| Cisen Pharmaceutical | 3.40B |
| Guizhou Bailing Group Pharmaceutical | 2.56B |
| Jinghua Pharmaceutical Group | 1.48B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.45B |
| Hunan Er-Kang Pharmaceutical | 1.05B |
| Chongqing Pharscin Pharmaceutical | 798.78M |